Search

Your search keyword '"Kälviäinen, Reetta"' showing total 730 results

Search Constraints

Start Over You searched for: Author "Kälviäinen, Reetta" Remove constraint Author: "Kälviäinen, Reetta"
730 results on '"Kälviäinen, Reetta"'

Search Results

251. Temporal changes in the incidence of epilepsy in Finland: Nationwide study

252. Carotid stenosis degree in CT angiography: assessment based on luminal area versus luminal diameter measurements.

254. [sup 18]F]FDG-PET Reveals Temporal Hypometabolism in Patients With Temporal Lobe Epilepsy Even When Quantitative MRI and Histopathological Analysis Show Only Mild Hippocampal Damage.

256. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries.

257. Cognitive functioning in new-onset juvenile myoclonic epilepsy.

258. Management of prolonged epileptic seizures and status epilepticus in palliative care patients.

259. Long-term Study With Gabapentin in Patients With Drug-Resistant Epileptic Seizures

260. Treatment delay in status epilepticus – more effective prehospital symptom recognition warranted.

261. MR Volumetric Analysis of The Piriform Cortex and Cortical Amygdala in Drug-Refractory Temporal Lobe Epilepsy

262. European trends in epilepsy surgery

263. Analysis of shared heritability in common disorders of the brain

264. Analysis of shared heritability in common disorders of the brain

265. Analysis of shared heritability in common disorders of the brain

266. Analysis of shared heritability in common disorders of the brain

267. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A

268. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study

270. Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.

271. Detecting negative myoclonus during long-term home measurements using wearables.

272. Propofol in the treatment of refractory status epilepticus.

273. The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?

274. A FinnGen pilot clinical recall study for Alzheimer's disease.

275. Trigger Development for the Improvement of Neurological Patient Care.

277. No reversion in vigabatrin-associated visual field defects

280. Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype.

283. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).

284. Vigabatrin and Carbamazepine Monotherapy for Newly Diagnosed Epilepsy-Reply

285. Impact of drug treatment and drug interactions in post-stroke epilepsy.

286. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial

287. Wearable monitoring of positive and negative myoclonus in progressive myoclonic epilepsy type 1.

288. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.

289. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.

290. Lacosamide in patients with epilepsy of cerebrovascular etiology.

292. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.

293. Epilepsy priorities in Europe: A report of the ILAE- IBE Epilepsy Advocacy Europe Task Force.

294. Valproate in the treatment of epilepsy in girls and women of childbearing potential.

295. Reduced cortical activation in inferior frontal junction in Unverricht–Lundborg disease (EPM1) – A motor fMRI study.

296. Distinct gene-set burden patterns underlie common generalized and focal epilepsies

297. Long-term memory performance after surgical treatment of unilateral temporal lobe epilepsy (TLE).

298. TMS-EEG reveals impaired intracortical interactions and coherence in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1).

299. Thickened skull, scoliosis and other skeletal findings in Unverricht–Lundborg disease link cystatin B function to bone metabolism

300. Non-invasive preoperative localization of primary motor cortex in epilepsy surgery by navigated transcranial magnetic stimulation

Catalog

Books, media, physical & digital resources